GSG GENII Software Group acquires iVention

17-Mar-2023 - Netherlands

GSG GENII Software Group announces that it has completed the acquisition of iVention. iVention provides laboratories in a wide range of industries with its powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for and around the laboratory process. Based in Zwolle, The Netherlands, iVention deploys its solutions via its Cloud Based Laboratory automation Platform that combines all essential lab automation features in a single system.

Computer-generated image

Symbolic image

As the ultimate laboratory management tool iLES improves efficiency and quality by streamlining workflows and managing and computerizing both research and routine work – even in highly regulated environments.  With iLES, laboratories benefit from automatic updates, unlock real-time information, ensure data integrity and regulatory compliance, while saving time and cost by efficient process automation and reduced manual data handling. 

iVention becomes part of GENII’s Laboratories business unit, joining other specialists such as ICD and Blomesystem as GENII continues to build out its clinical and non-clinical software solutions for the laboratory sector.  As part of a larger Laboratories business, iVention will leverage GENII’s Laboratories customer base and geographical footprint, receiving investment to achieve its ambition of becoming a global top 5 iLES solution, competing directly with incumbent players and winning market share as the modern application of choice. 

Oscar Kox, iVention CEO, said, “We are delighted to join GENII and its Laboratories team. GENII is very committed to this sector, and the opportunity to become part of this, utilising our iLES technology platform across this vertical is very exciting. I believe we are stronger together, and our combined industry expertise and best-in-class product will enable us to shape the advanced, automated technology era for labs over the coming years.”

Matthias Siekmann, Group CEO, GENII, stated, “Our acquisition of iVention further progresses GENII’s strategy of being the best home for market-leading, niche enterprise software businesses. Together we will make a strong push to change the lab automation world and establish iVention as a leading product with the most modern technology, future-proofed and financially backed by GENII.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances